Skip to content
Open access

Generation and evaluation of multimers of anti C-reactive protein Nb and alkaline phosphatase based on three self-assembly peptides

Aug 2026 · Experimental and Therapeutic Medicine · Vol 32 · 0 citations · 41 references
Medicine

TL;DR

A novel nanobody-fusion protein platform was established that functioned as high-affinity binders for target antigens and heat-stable signal tracers for immunoassay detection and quantitative analysis, providing a novel type of thermostable immunoreagent.

Abstract

Nanobodies (Nbs) have been extensively utilized in medical diagnosis and therapies due to their advantages, such as ease of genetic manipulation and efficient soluble expression in prokaryotic systems. However, enhancing their binding affinity to antigens to match or even exceed that of polyclonal antibodies for high-sensitivity bioassays remains a challenge. Therefore, in the present study, a novel strategy to enhance the binding affinity of antibodies to antigens was developed by fusing an anti-C-reactive protein Nb (CRPNb) to the N-terminus of self-assembling peptides such as right-handed coiled coil [RHCC; derived from a right-handed coiled-coil peptide of an archaebacterium (Staphylothermus marinus)], verotoxin (VTB; the B-subunit of Escherichia coli verotoxin) and C4-binding protein (C4bp; derived from human plasma C4-binding protein α-chain). For functional detection, alkaline phosphatase (AP) was further fused to the C-terminus of RHCC, VTB and C4bp, respectively. This approach enabled the formation of CRPNb-RHCC-AP tetramers, CRPNb-VTB-AP pentamers and CRPNb-C4bp-AP heptamers. These were then expressed as soluble cytoplasmic proteins in the E. coli strain BL21 (DE3) and purified by imidazole elution. The protein expression was assessed by western blotting. Additionally, the stability of the multimeric constructs was evaluated using a direct ELISA, whilst their sensitivity was assessed using a competitive ELISA. The CRPNb-VTB-AP pentamers and CRPNb-RHCC-AP tetramers demonstrated antigen-specific recognition and enhanced affinity compared with the CRP-AP monomer based on a direct ELISA. Furthermore, they exhibited good thermal stability based on a direct ELISA. At 80˚C, CRPNb-VTB-AP, CRPNb-AP and CRPNb-RHCC-AP retained ~85, 75 and 60% activity, while CRPNb-H only retained ~40%. After incubation at 80˚C for 55 min, the two multimers still maintained ~40% activity. The results suggested them to be suitable for storage and transportation at ambient temperatures. In conclusion, a novel nanobody-fusion protein platform was established in the present study. The fusion proteins functioned as high-affinity binders for target antigens and heat-stable signal tracers for immunoassay detection and quantitative analysis, providing a novel type of thermostable immunoreagent.

Read PDF

Similar papers

Oct 2026

A Bifunctional Protein G-Streptavidin Fusion Protein for Antibody Detection and Circulating Tumor Cell Enrichment.

Circulating tumor cells (CTCs) are important biomarkers of cancer metastasis; however, their extremely low abundance in the bloodstream poses significant challenges for sensitive and specific detection. Bifunctional fusion proteins that combine an IgG-binding domain with a signal-amplifying module offer a promising str...

Xin-Yi Mao, Lin Chen, Ang Liu et al. · 0 citations
Review Open access Aug 2026

Overcoming the Limitations of Protein A: Evolution of Bacterial Protein-Based and Synthetic Affinity Ligands for High-Performance IgG Purification

The key finding is that the reliable and time-tested resins like those based on protein A continue to dominate the market, although future trends also point toward smaller, more stable, and cost-effective synthetic ligands for specific applications.

L. N. Ikryannikova, M. N. Tereshin, Milena V. Baskova et al. · 0 citations
Oct 2026

B-149 From Polyclonal to Recombinant: A Proteomics Workflow for Anti-Idiotype Antibody Development

Anti-idiotype antibodies are essential tools for therapeutic drug monitoring of biologic therapies in cancer, inflammatory bowel disease, and rheumatoid arthritis. While several platforms exist for their development, including B-cell immortalization and phage display, we employ a proteomics-based mass spectrometr...

J. Crha, T. Le Bihan, T. N. de Villavicencio Diaz et al. · 0 citations
Open access Sep 2026

Design and synthesis of reagents for generation and characterization of high-affinity antibodies for a Staphylococcus aureus serotype 8 disaccharide.

Staphylococcus aureus is a common, opportunistic pathogen, and drug resistance of this organism continues to rise. Substantial efforts have been made to generate vaccines that provide long-lasting protection; however, these have fallen short. High-affinity antibodies could represent a useful treatment modality, taking...

S. Mata, S. Deng, Jeffery A. Noble et al. · 0 citations
Open access Sep 2026

In vitro evaluation of novel consensus-sequence-generated Brevinin-2 antimicrobial peptides

The consensus-sequence approach toward novel Brevinin-2 AMP discovery via alignment combined with in vitro antimicrobial analysis shows promise to test and initially validate other peptides, and establishes a streamlined pipeline for Brevinin-2 peptide development.

Colin M. McDowell, Jessica D. Carder, J. Brozik et al. · 0 citations
Oct 2026

Development of an Intein-Based Bioprocessing Platform for Recombinant Production of a Potent Antimicrobial Peptide: Lasioglossin-III.

The rapid emergence of antimicrobial resistance has intensified the demand for novel anti-infective agents, positioning antimicrobial peptides (AMPs) as promising therapeutic alternatives. However, large scale production of AMPs remains challenging due to their small size, cationic nature, host toxicity, and high cost...

Atul Kumar, M. N. Galodiya, Shankar Chakma et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.